BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitsui A, Suzuki S. Immunosuppressive effect of mycophenolic acid. J Antibiot (Tokyo). 1969;22:358-363. [PMID: 5345678 DOI: 10.7164/antibiotics.22.358] [Cited by in Crossref: 78] [Cited by in F6Publishing: 57] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatol Clin 2000;18:1-11. [PMID: 10626106 DOI: 10.1016/s0733-8635(05)70141-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
2 Coscia LA, Armenti DP, King RW, Sifontis NM, Constantinescu S, Moritz MJ. Update on the Teratogenicity of Maternal Mycophenolate Mofetil. J Pediatr Genet 2015;4:42-55. [PMID: 27617117 DOI: 10.1055/s-0035-1556743] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
3 Jones AE, Wilson HK, Meath P, Meng X, Holt DW, Johnston A, Oellerich M, Armstrong VW, Stachulski AV. Convenient syntheses of the in vivo carbohydrate metabolites of mycophenolic acid: reactivity of the acyl glucuronide. Tetrahedron Letters 2009;50:4973-7. [DOI: 10.1016/j.tetlet.2009.06.060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Muth WL, Nash CH 3rd. Biosynthesis of mycophenolic acid: purification and characterization of S-adenosyl-L-methionine: demethylmycophenolic acid O-methyltransferase. Antimicrob Agents Chemother 1975;8:321-7. [PMID: 241289 DOI: 10.1128/AAC.8.3.321] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
5 Eugui EM, Mirkovich A, Allison AC. Lymphocyte-Selective Antiproliferative and Immunosuppressive Effects of Mycophenolic Acid in Mice. Scand J Immunol 1991;33:175-83. [DOI: 10.1111/j.1365-3083.1991.tb03747.x] [Cited by in Crossref: 149] [Cited by in F6Publishing: 133] [Article Influence: 5.0] [Reference Citation Analysis]
6 Kitchin JES, Pomeranz MK, Pak G, Washenik K, Shupack JL. Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses. Journal of the American Academy of Dermatology 1997;37:445-9. [DOI: 10.1016/s0190-9622(18)30747-3] [Cited by in Crossref: 37] [Article Influence: 1.5] [Reference Citation Analysis]
7 Stierle AA, Stierle DB. Bioactive Secondary Metabolites Produced by the Fungal Endophytes of Conifers. Natural Product Communications 2015;10:1934578X1501001. [DOI: 10.1177/1934578x1501001012] [Cited by in Crossref: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Bentley R. Mycophenolic Acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 2000;100:3801-26. [PMID: 11749328 DOI: 10.1021/cr990097b] [Cited by in Crossref: 191] [Cited by in F6Publishing: 165] [Article Influence: 9.1] [Reference Citation Analysis]
9 Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N, Smith EP, Takeuchi K, Senda T, Kofuji S, Sasaki AT. Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story. Cancers (Basel) 2019;11:E1346. [PMID: 31514446 DOI: 10.3390/cancers11091346] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
10 Henry SD, Metselaar HJ, Lonsdale RC, Kok A, Haagmans BL, Tilanus HW, van der Laan LJ. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. Gastroenterology. 2006;131:1452-1462. [PMID: 17101321 DOI: 10.1053/j.gastro.2006.08.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 5.3] [Reference Citation Analysis]
11 Halle MB, Lee W, Yudhistira T, Kim M, Churchill DG. Mycophenolic Acid: Biogenesis, Compound Isolation, Biological Activity, and Historical Advances in Total Synthesis: Mycophenolic Acid: Biogenesis, Compound Isolation, Biological Activity, and Historical Advances in Total Synthesis. Eur J Org Chem 2019;2019:2315-34. [DOI: 10.1002/ejoc.201900245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000;47:215-45. [DOI: 10.1016/s0162-3109(00)00190-9] [Cited by in Crossref: 176] [Cited by in F6Publishing: 30] [Article Influence: 8.4] [Reference Citation Analysis]
13 Chopade SS, Dhaneshwar SS. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats. World J Gastroenterol 2018; 24(10): 1093-1106 [PMID: 29563754 DOI: 10.3748/wjg.v24.i10.1093] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Orvis AK, Wesson SK, Breza TS, Church AA, Mitchell CL, Watkins SW. Mycophenolate mofetil in dermatology. Journal of the American Academy of Dermatology 2009;60:183-99. [DOI: 10.1016/j.jaad.2008.08.049] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
15 Klotsman M, Sathyan G, Anderson WH, Garden OA, Shivanand P. Mycophenolic acid in patients with immune-mediated inflammatory diseases: From humans to dogs. J Vet Pharmacol Ther 2019;42:127-38. [PMID: 30375004 DOI: 10.1111/jvp.12731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Ye L, Li J, Zhang T, Wang X, Wang Y, Zhou Y, Liu J, Parekh HK, Ho W. Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells. Virus Res 2012;168:33-40. [PMID: 22728816 DOI: 10.1016/j.virusres.2012.06.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
17 Ferraris DM, Gelardi ELM, Garavaglia S, Miggiano R, Rizzi M. Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer. Biochem Soc Trans 2020;48:693-707. [PMID: 32311017 DOI: 10.1042/BST20191261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999;10:1366-80. [PMID: 10361877 DOI: 10.1681/ASN.V1061366] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
19 Halle MB, Yudhistira T, Lee WH, Mulay SV, Churchill DG. Diels-Alder and Stille Coupling Approach for the Short Protecting-Group-Free Synthesis of Mycophenolic Acid, Its Phenylsulfenyl and Phenylselenyl Analogues, and Reactive Oxygen Species (ROS) Probing Capacity in Water. Org Lett 2018;20:3557-61. [PMID: 29809015 DOI: 10.1021/acs.orglett.8b01327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
20 Sollinger HW. A few memories from the beginning... Transplantation 2005;80:S178-80. [PMID: 16251850 DOI: 10.1097/01.tp.0000186385.91735.5d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Luly JR. Chapter 22. Mechanism-Based Immunosuppressants. Elsevier; 1991. pp. 211-20. [DOI: 10.1016/s0065-7743(08)61209-9] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
22 Srinivas TR, Kaplan B, Meier-Kriesche HU. Mycophenolate mofetil in solid-organ transplantation. Expert Opin Pharmacother. 2003;4:2325-2345. [PMID: 14640931 DOI: 10.1517/14656566.4.12.2325] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
23 Allison AC, Eugui EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol. 1993;14:353-380. [PMID: 8322167 DOI: 10.1007/bf00192309] [Cited by in Crossref: 88] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
24 Jonsson CA, Erlandsson M, Svensson L, Mölne J, Carlsten H. Mycophenolate Mofetil Ameliorates Perivascular T Lymphocyte Inflammation and Reduces the Double-Negative T Cell Population in SLE-Prone MRLlpr/lpr Mice. Cellular Immunology 1999;197:136-44. [DOI: 10.1006/cimm.1999.1570] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
25 Covarrubias-zúnniga A, Diaz-dominguez J, Olguín-uribe JS. SYNTHESIS OF 6-ALLYL-7-HYDROXY-5-METHOXY-4-METHYLPHTHALIDE, A KEY INTERMEDIATE IN THE SYNTHESIS OF MYCOPHENOLIC ACID. Synthetic Communications 2001;31:1373-81. [DOI: 10.1081/scc-100104047] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
26 Covarrubias-zúñiga A, Gonzalez-lucas A, Domı́nguez MM. Total synthesis of mycophenolic acid. Tetrahedron 2003;59:1989-94. [DOI: 10.1016/s0040-4020(03)00102-9] [Cited by in Crossref: 19] [Article Influence: 1.1] [Reference Citation Analysis]
27 Hermann LL, Coombs KM. Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment. J Virol 2004;78:6171-9. [PMID: 15163710 DOI: 10.1128/JVI.78.12.6171-6179.2004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
28 Shoji Y, Fukumura T, Kudo M, Yanagawa A, Shimada J, Mizushima Y. Effect of Topical Preparation of Mycophenolic Acid on Experimental Allergic Contact Dermatitis of Guinea-pigs Induced by Dinitrofluorobenzene. Journal of Pharmacy and Pharmacology 1994;46:643-6. [DOI: 10.1111/j.2042-7158.1994.tb03874.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
29 Meza-aviña ME, Ordoñez M, Fernández-zertuche M, Rodríguez-fragoso L, Reyes-esparza J, Martínez de los Ríos-corsino AA. Synthesis of some monocyclic analogues of mycophenolic acid via the Johnson ortho ester Claisen rearrangement. Bioorganic & Medicinal Chemistry 2005;13:6521-8. [DOI: 10.1016/j.bmc.2005.07.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
30 Bianchi-Smiraglia A, Wawrzyniak JA, Bagati A, Marvin EK, Ackroyd J, Moparthy S, Bshara W, Fink EE, Foley CE, Morozevich GE, Berman AE, Shewach DS, Nikiforov MA. Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity. Cell Death Differ 2015;22:1858-64. [PMID: 25909885 DOI: 10.1038/cdd.2015.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
31 Filler G, Alvarez-Elías AC, McIntyre C, Medeiros M. The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. Pediatr Nephrol 2017;32:21-9. [PMID: 26921212 DOI: 10.1007/s00467-016-3352-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
32 Sintchak MD, Nimmesgern E. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology 2000;47:163-84. [PMID: 10878288 DOI: 10.1016/s0162-3109(00)00193-4] [Cited by in Crossref: 154] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
33 Pindelska E, Sokal A, Kolodziejski W. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques. Advanced Drug Delivery Reviews 2017;117:111-46. [DOI: 10.1016/j.addr.2017.09.014] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
34 Hesse U, Troisi R, Jacobs B, Van Vlem B, De Hemptinne B, Van Holder R, Vermassen F, De Roose J, Lameire N. A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants: Quadruple immunosuppression in pancreas-kidney transplants. Clin Transplantation 2000;14:340-4. [DOI: 10.1034/j.1399-0012.2000.140410.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
35 Ettenger R, Bartosh S, Choi L, Zhu W, Niederberger W, Campestrini J, Bastien MC, Schmouder R. Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients. Pediatr Transplant. 2005;9:780-787. [PMID: 16269051 DOI: 10.1111/j.1399-3046.2005.00386.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
36 Wu X, Zhong H, Song J, Damoiseaux R, Yang Z, Lin S. Mycophenolic Acid Is a Potent Inhibitor of Angiogenesis. ATVB 2006;26:2414-6. [DOI: 10.1161/01.atv.0000238361.07225.fc] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
37 Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses. J Am Acad Dermatol 1997;37:445-9. [PMID: 9308561 DOI: 10.1016/s0190-9622(97)70147-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
38 Weigel G, Bertalanffy P, Dubsky P, Griesmacher A, Wolner E. Mycophenolic acid influences T helper 2 (Th2) cytokine induced expression of intercellular cell adhesion molecule-1 (ICAM-1) on human endothelial cells. Clin Chem Lab Med 1999;37:253-7. [PMID: 10353468 DOI: 10.1515/CCLM.1999.044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Assmann T, Ruzicka T. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications. Clinics in Dermatology 2002;20:505-14. [DOI: 10.1016/s0738-081x(02)00271-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
40 Allison AC, Eugui EM. Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil. Immunol Rev 1993;136:5-28. [DOI: 10.1111/j.1600-065x.1993.tb00652.x] [Cited by in Crossref: 273] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
41 Simonetti SO, Larghi EL, Bracca AB, Kaufman TS. Angular tricyclic benzofurans and related natural products of fungal origin. Isolation, biological activity and synthesis. Nat Prod Rep 2013;30:941-69. [PMID: 23719995 DOI: 10.1039/c3np70014c] [Cited by in Crossref: 66] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
42 Wu JC. Mycophenolate mofetil: Molecular mechanisms of action. Perspectives in Drug Discovery and Design 1994;2:185-204. [DOI: 10.1007/bf02171743] [Cited by in Crossref: 87] [Article Influence: 3.2] [Reference Citation Analysis]
43 Hughes SE, Gruber SA. New Immunosuppressive Drugs in Organ Transplantation. The Journal of Clinical Pharmacology 1996;36:1081-92. [DOI: 10.1002/j.1552-4604.1996.tb04160.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
44 Jekkel A, Barta I, Kónya A, Sütő J, Boros S, Horváth G, Ambrus G. Microbiological transformation of mycophenolic acid. Journal of Molecular Catalysis B: Enzymatic 2001;11:423-6. [DOI: 10.1016/s1381-1177(00)00146-6] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
45 Tauber PA, Pickl WF. Pharmacological targeting of allergen-specific T lymphocytes. Immunol Lett 2017;189:27-39. [PMID: 28322861 DOI: 10.1016/j.imlet.2017.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Ingle GR, Shah T. Enteric-coated mycophenolate sodium for transplant immunosuppression. American Journal of Health-System Pharmacy 2005;62:2252-9. [DOI: 10.2146/ajhp040380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
47 Zand MS. Immunosuppression and immune monitoring after renal transplantation. Semin Dial 2005;18:511-9. [PMID: 16398715 DOI: 10.1111/j.1525-139X.2005.00098.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
48 Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998;66:1751-9. [PMID: 9884272 DOI: 10.1097/00007890-199812270-00032] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
49 Spatz S, Rudnicka A, Mcdonald CJ. Mycophenolic acid in psoriasis. British Journal of Dermatology 1978;98:429-35. [DOI: 10.1111/j.1365-2133.1978.tb06537.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
50 Mcdonald CJ. The uses of systemic chemotherapeutic agents in psoriasis. Pharmacology & Therapeutics 1981;14:1-24. [DOI: 10.1016/0163-7258(81)90008-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
51 Hausen B, Morris RE. REVIEW OF IMMUNOSUPPRESSION FOR LUNG TRANSPLANTATION. Clinics in Chest Medicine 1997;18:353-66. [DOI: 10.1016/s0272-5231(05)70384-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Epinette WW, Parker CM, Jones EL, Greist MC. Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety. J Am Acad Dermatol. 1987;17:962-971. [PMID: 3429723 DOI: 10.1016/s0190-9622(87)70285-0] [Cited by in Crossref: 173] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
53 Sidwell RW, Barnard DL. Respiratory syncytial virus infections: Recent prospects for control. Antiviral Research 2006;71:379-90. [DOI: 10.1016/j.antiviral.2006.05.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
54 Brookes PA, Cordes J, White AJP, Barrett AGM. Total Synthesis of Mycophenolic Acid by a Palladium-Catalyzed Decarboxylative Allylation and Biomimetic Aromatization Sequence: Total Synthesis of Fungal Natural Products. Eur J Org Chem 2013;2013:7313-9. [DOI: 10.1002/ejoc.201300974] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
55 Covarrubias-zúñiga A, González-lucas A. A total synthesis of mycophenolic acid. Tetrahedron Letters 1998;39:2881-2. [DOI: 10.1016/s0040-4039(98)00423-7] [Cited by in Crossref: 19] [Article Influence: 0.8] [Reference Citation Analysis]
56 Fernandes RA, Chowdhury AK, Kattanguru P. The Orthoester Johnson-Claisen Rearrangement in the Synthesis of Bioactive Molecules, Natural Products, and Synthetic Intermediates - Recent Advances: Orthoester Johnson-Claisen Rearrangements. Eur J Org Chem 2014;2014:2833-71. [DOI: 10.1002/ejoc.201301033] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
57 Jones EA. Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis: Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis. Hepatology 2002;35:258-62. [DOI: 10.1053/jhep.2002.31607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]